• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Body weight may not be the best way to assess cardiometabolic risk in some minority populations

byDeepti Shroff KarhadeandCaitlyn Hui
April 4, 2017
in Cardiology, Chronic Disease, Endocrinology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. All racial/ethnic minority groups evaluated, compared with Caucasian patients, had a statistically higher prevalence of metabolic abnormality but normal body weight (MAN).

2. Using BMI as a method of screening for increased cardiometabolic risk may leave out a significant proportion of vulnerable patients.

Evidence Rating Level: Good (2)

Study Rundown: Body weight is a common method used to screen for cardiometabolic disease, as overweight and obesity are well-known risk factors. However, patients with a healthy weight may also have increased cardiometabolic risk. It has been suggested that the relationship between obesity and cardiometabolic abnormalities may vary among ethnic groups. The authors of this study aimed to determine the prevalence and correlates of the phenotype of metabolic abnormality but normal weight (MAN) for 5 racial/ethnic groups. In general, they observed that minority groups had a higher prevalence of MAN. This study has several limitations. Specifically, there are differences in timing of data collection between studies used, which may have resulted in differences in the prevalence of overweight and obesity between the 2 cohorts. Overall, this study suggests that an alternative-screening tool for cardiometabolic risk may be more appropriate in order to avoid missing patients with normal body weights but increased risk.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Ethnic Group Differences in Cardiometabolic Disease Risk Factors Independent of Body Mass Index among American Youth

In-Depth [retrospective cohort]: The authors of this study conducted a cross-sectional analysis using 2 community-based cohorts, MESA (Multi-Ethnic Study of Atherosclerosis) and the MASALA (Mediators of Atherosclerosis in South Asians Living in America). Statistics were calculated using pooled data from the two cohorts. In general, there was an increased prevalence of MAN in all 5 racial/ethnic groups compared to white patients. Specifically, the prevalence of MAN was 21.0% (95% CI, 18.4%-23.9%) in whites, 32,2% (CI, 27.3% to 37.4%) in Chinese Americans, 31.1% (CI, 26.3% to 36.3%) in African Americans, 38.5% (CI, 32.6% to 44.6%) in Hispanics, and 43.6% (CI, 36.8% to 50.6%) in South Asians.

RELATED REPORTS

Tirzepatide reduces body weight and improves cardiometabolic function in patients with obesity

Life expectancy disparities have increased between ethnic groups in certain states

#VisualAbstract: Tirzepatide Once Weekly for the Treatment of Obesity

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ethnicityobesityoverweight
Previous Post

Tdap vaccination in pregnancy effective in preventing pertussis in infants

Next Post

Being overweight at any point in adulthood increases risk for death

RelatedReports

Many new pediatric asthma cases attributable to obesity
Cardiology

Tirzepatide reduces body weight and improves cardiometabolic function in patients with obesity

July 22, 2022
Institute of Medicine identifies cost variation between geographic regions
Public Health

Life expectancy disparities have increased between ethnic groups in certain states

July 7, 2022
#VisualAbstract: Tirzepatide Once Weekly for the Treatment of Obesity
StudyGraphics

#VisualAbstract: Tirzepatide Once Weekly for the Treatment of Obesity

July 7, 2022
Meeting families, demographic information affect child abuse work-up
Pediatrics

Subsidization of supermarkets may help reduce obesity risk in children

June 27, 2022
Next Post
FDA-approved weight loss medications associated with weight loss at one year

Being overweight at any point in adulthood increases risk for death

Smoking during pregnancy associated with aerobic fitness of children

2 Minute Medicine Rewind April 3, 2017

Adding daratumumab increases progression free survival in multiple myeloma

Multiple myeloma management with lenalidomide, bortezomib and dexamethasone associated with prolonged progression-free survival

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ciprofol comparable to propofol for general anesthesia induction for gynecological surgery
  • Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy
  • Type of compensation model influences gender pay gap in primary care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.